Invention Grant
US09200000B2 Imidazo[5,1-f][1,2,4]triazines for the treatment of neurological disorders
有权
咪唑并[5,1-f] [1,2,4]三嗪用于治疗神经系统疾病
![Imidazo[5,1-f][1,2,4]triazines for the treatment of neurological disorders](/docs/US/2015-12-01/US09200000B2/abs.jpg.600x600.jpg)
- Patent Title: Imidazo[5,1-f][1,2,4]triazines for the treatment of neurological disorders
- Patent Title (中): 咪唑并[5,1-f] [1,2,4]三嗪用于治疗神经系统疾病
-
Application No.: US14069640Application Date: 2013-11-01
-
Publication No.: US09200000B2Publication Date: 2015-12-01
- Inventor: Christopher John Helal , Thomas Allen Chappie , John Michael Humphrey , Patrick Robert Verhoest , Eddie Yang
- Applicant: Pfizer Inc.
- Applicant Address: US NY New York
- Assignee: Pfizer Inc.
- Current Assignee: Pfizer Inc.
- Current Assignee Address: US NY New York
- Agent Richard V. Zanzalari
- Main IPC: C07D487/04
- IPC: C07D487/04
![Imidazo[5,1-f][1,2,4]triazines for the treatment of neurological disorders](/abs-image/US/2015/12/01/US09200000B2/abs.jpg.150x150.jpg)
Abstract:
The present invention relates to compounds of the Formula and pharmaceutically acceptable salts thereof, to processes for the preparation of, intermediates used in the preparation of, and compositions containing such compounds and the uses of such compounds as a method for the treatment of a disease or condition selected from the group consisting of central nervous system disorders, cognitive disorders, schizophrenia, dementia and other disorders in a mammal.
Public/Granted literature
- US20140066622A1 Imidazo[5,1-f][1,2,4]Triazines For The Treatment of Neurological Disorders Public/Granted day:2014-03-06
Information query
